← Browse by Condition
Medical Condition
locally advanced cervical cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT06079671 Phase 3
Recruiting
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Enrollment
800 pts
Location
United States, Brazi...
Sponsor
AstraZeneca
NCT06771193
Recruiting
Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy
Enrollment
200 pts
Location
Italy
Sponsor
MSD Italia S.r.l.